Package Leaflet: Information for the User
ADROVANCE 70mg/2.800UI tablets
ADROVANCE 70mg/5.600UI tablets
alendronic acid/colecalciferol
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
What is ADROVANCE?
ADROVANCE is a tablet that contains two active substances, alendronic acid (commonly called alendronate) and colecalciferol, known as vitamin D3.
What is alendronate?
Alendronate belongs to a group of non-hormonal medicines called bisphosphonates. Alendronate prevents bone loss that occurs in women after they have entered menopause, and helps to rebuild bone. It reduces the risk of vertebral and hip fractures.
What is vitamin D?
Vitamin D is an essential nutrient, necessary for calcium absorption and to maintain healthy bones. The body can only absorb calcium properly from food if it contains sufficient vitamin D, which occurs in very few foods. The main source of vitamin D is production in the skin, through exposure to sunlight. As we age, our skin produces less vitamin D. Vitamin D deficiency can lead to bone loss and osteoporosis, and in severe cases can cause muscle weakness that can result in falls and increase the risk of fractures.
What is ADROVANCE used for?
Your doctor has prescribed ADROVANCE to treat your osteoporosis and because you are at risk of having a vitamin D deficiency. It reduces the risk of vertebral and hip fractures in women after menopause.
What is osteoporosis?
Osteoporosis causes wear and tear and fragility of the bones. It is common in women after menopause. During menopause, the ovaries stop producing a type of female hormone, estrogen, which helps to maintain a healthy skeleton. As a result, bone loss occurs and the bones become more fragile. The earlier a woman reaches menopause, the greater the risk of osteoporosis.
Initially, osteoporosis does not present symptoms. However, if left untreated, it can cause bone fractures. Although these are usually painful, vertebral fractures can go unnoticed until they cause loss of height. Weakened bones can break during normal daily activity, such as when getting up or from minor injuries that would not normally break a normal bone. Bone fractures usually occur in the hip, spine, or wrist, and can cause not only pain but also significant problems such as a hunched posture (dowager's hump) and loss of mobility.
How can osteoporosis be treated?
As well as your treatment with ADROVANCE, your doctor may suggest that you make changes to your lifestyle to help slow down your disease, such as:
Stopping smokingSmoking seems to increase the rate of bone loss and, therefore, may increase your risk of bone fractures.
ExerciseLike muscles, bones need exercise to stay strong and healthy. Consult your doctor before starting any exercise program.
Eating a balanced dietYour doctor may advise you on your diet or on whether you should take any dietary supplements.
Do not take ADROVANCE
If you think any of these apply to you, do not take the tablets. Consult your doctor and follow their advice.
Warnings and precautions
Consult your doctor or pharmacist before starting to take ADROVANCE if:
You may be advised to have a dental check-up before starting treatment with ADROVANCE.
It is important to maintain good oral hygiene when taking ADROVANCE. You should have regular dental check-ups during your treatment and should contact your doctor or dentist if you experience any problems in your mouth or teeth, such as tooth loss, pain, or inflammation.
Irritation, inflammation, or ulcers of the throat (esophagus - the tube that connects your mouth to your stomach) may occur, often with symptoms of chest pain, heartburn, difficulty or pain when swallowing, especially if patients do not drink a full glass of water and/or if they lie down less than 30 minutes after taking ADROVANCE. These side effects may worsen if patients continue to take ADROVANCE after developing these symptoms.
Girls and adolescents
ADROVANCE should not be given to girls and adolescents under 18 years of age.
Other medicines and ADROVANCE
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
It is likely that calcium supplements, antacids, and some oral medicines will interfere with the absorption of ADROVANCE if taken at the same time. Therefore, it is important that you follow the instructions given in section 3 and wait at least 30 minutes before taking any other medicine or supplement.
Certain medicines for rheumatism or long-term pain called NSAIDs (such as acetylsalicylic acid or ibuprofen) may cause digestive problems. Therefore, caution should be exercised if these medicines are taken at the same time as ADROVANCE.
It is likely that certain medicines or food additives may prevent the absorption of vitamin D from ADROVANCE, including artificial fat substitutes, mineral oils, weight loss medication, orlistat, and cholesterol-lowering medicines, cholestyramine, and colestipol. Medicines for epilepsy (seizures) (such as phenytoin or phenobarbital) may decrease the effectiveness of vitamin D. Individually, the need for additional vitamin D supplements may be considered.
Taking ADROVANCE with food and drinks
It is likely that food and drinks (including mineral water) will reduce the effectiveness of ADROVANCE if taken at the same time. Therefore, it is important that you follow the advice given in section 3. You should wait at least 30 minutes before taking any food and drinks except water.
Pregnancy and breastfeeding
ADROVANCE is only intended for use in postmenopausal women. You should not take ADROVANCE if you are pregnant or think you may be pregnant, or if you are breastfeeding.
Driving and using machines
Side effects with ADROVANCE (such as blurred vision, dizziness, and severe bone, muscle, or joint pain) have been reported that may affect your ability to drive or use machines (see section 4). If you experience any of these side effects, do not drive until you feel better.
ADROVANCE contains lactose and sucrose.
If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
ADROVANCE contains sodium.
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".
Follow exactly the instructions for administration of ADROVANCE given by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.
Take one ADROVANCE tabletonce a week.
Follow these instructions carefully.
It is very important that you follow the instructions 2), 3), 4), and 5) to help the ADROVANCE tablet reach your stomach quickly and help reduce the possible irritation of the throat (esophagus - the tube that connects your mouth to your stomach).
Do not crush or chew the tablet or allow it to dissolve in your mouth, due to the possibility of ulcers in the mouth.
If you take more ADROVANCE than you should
If you take too many tablets by mistake, drink a full glass of milk and go to your doctor immediately. Do not induce vomiting and do not lie down.
If you forget to take ADROVANCE
If you forget a dose, take a single tablet the next morning when you remember. Do not take two tablets on the same day.Then, take one tablet once a week, on the original day you chose.
If you stop taking ADROVANCE
It is important that you take ADROVANCE while your doctor prescribes it for you. As it is not known how long you should take ADROVANCE, you should discuss with your doctor periodically the need to continue treatment with this medicine to determine if ADROVANCE is still suitable for you.
An Instruction Card is included in the ADROVANCE pack. It contains important information to remind you how to take ADROVANCE correctly.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Consult your doctor immediatelyif you experience any of the following side effects, which may be serious and require urgent medical treatment:
Frequent (may affect up to 1 in 10 people):
Rare (may affect up to 1 in 1,000 people):
Frequency not known (cannot be estimated from the available data)
Other side effects include
Very frequent (may affect more than 1 in 10 people):
Frequent (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Very rare (may affect up to 1 in 10,000 people):
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date is the last day of the month shown.
Store in the original blister pack to protect from moisture and light.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition of ADROVANCE
The active ingredients are alendronic acid and colecalciferol (vitamin D3). Each ADROVANCE 70 mg/2,800 IU tablet contains 70 mg of alendronic acid (as sodium trihydrate salt) and 70 micrograms (2,800 IU) of colecalciferol (vitamin D3). Each ADROVANCE 70 mg/5,600 IU tablet contains 70 mg of alendronic acid (as sodium trihydrate salt) and 140 micrograms (5,600 IU) of colecalciferol (vitamin D3).
The other ingredients are microcrystalline cellulose (E-460), anhydrous lactose (see section 2), medium-chain triglycerides, gelatin, sodium croscarmellose, sucrose (see section 2), colloidal silicon dioxide, magnesium stearate (E-572), butylhydroxytoluene (E-321), modified cornstarch, and sodium aluminum silicate (E-554).
Appearance and Packaging of the Product
The ADROVANCE 70 mg/2,800 IU tablets are white to off-white, modified capsule-shaped, and marked with a bone silhouette on one side and "710" on the other. The ADROVANCE 70 mg/2,800 IU tablets are available in packs containing 2, 4, 6, or 12 tablets.
The ADROVANCE 70 mg/5,600 IU tablets are white to off-white, modified rectangle-shaped, and marked with a bone silhouette on one side and "270" on the other. The ADROVANCE 70 mg/5,600 IU tablets are available in packs containing 2, 4, or 12 tablets.
Only some pack sizes may be marketed.
Marketing Authorization Holder N.V. OrganonKloosterstraat 65349 AB OssNetherlands | Manufacturer Merck Sharp & Dohme B.V.Waarderweg 392031 BN HaarlemNetherlands Organon Heist bv Industriepark 30 2220 Heist-op-den-Berg Belgium |
For further information about this medicinal product, please contact the local representative of the marketing authorization holder:
België/Belgique/Belgien Organon Belgium Tél/Tel: 0080066550123 (+32 2 2418100) dpoc.benelux@organon.com | Lietuva Organon Pharma B.V. Lithuania atstovybe Tel.: +370 52041693 dpoc.lithuania@organon.com |
България Органон България (?.?.) ?.?. - ???? ???????? Тел: +359 2 806 3030 dpoc.bulgaria@organon.com | Luxembourg/Luxemburg Organon Belgium Tél/Tel: 0080066550123 (+32 2 2418100) dpoc.benelux@organon.com |
Česká republika Organon Czech Republic s.r.o. Tel: +420 233 010 300 dpoc.czech@organon.com | Magyarország Organon Hungary Kft. Tel.: +36 1 766 1963 dpoc.hungary@organon.com |
Danmark Organon Denmark ApS Tlf: +45 4484 6800 info.denmark@organon.com | Malta Organon Pharma B.V., Cyprus branch Tel: +356 2277 8116 dpoc.cyprus@organon.com |
Deutschland Organon Healthcare GmbH Tel: 0800 3384 726 (+49 (0) 89 2040022 10) dpoc.germany@organon.com | Nederland N.V. Organon Tel.: 00800 66550123 (+32 2 2418100) dpoc.benelux@organon.com |
Eesti Organon Pharma B.V. Estonian RO Tel: +372 66 61 300 dpoc.estonia@organon.com | Norge Organon Norway AS Tlf: +47 24 14 56 60 info.norway@organon.com |
Ελλάδα N.V. Organon Τηλ: +30-216 6008607 | Österreich Organon Healthcare GmbH Tel: +49 (0) 89 2040022 10 dpoc.austria@organon.com |
España Organon Salud, S.L. Tel: +34 91 591 12 79 organon_info@organon.com | Polska Organon Polska Sp. z o.o. Tel.: +48 22 105 50 01 organonpolska@organon.com |
France Organon France Tél: +33 (0) 1 57 77 32 00 | Portugal Organon Portugal, Sociedade Unipessoal Lda. Tel: +351?218705500 geral_pt@organon.com |
Hrvatska Organon Pharma d.o.o. Tel: +385 1 638 4530 dpoc.croatia@organon.com | România Organon Biosciences S.R.L. Tel: +40 21 527 29 90 dpoc.romania@organon.com |
Ireland Organon Pharma (Ireland) Limited Tel: +353 15828260 medinfo.ROI@organon.com | Slovenija Organon Pharma B.V., Oss, podružnica Ljubljana Tel: +386 1 300 10 80 dpoc.slovenia@organon.com |
Ísland Vistor hf. Sími: +354 535 7000 | Slovenská republika Organon Slovakia s. r. o. Tel: +421 2 44 88 98 88 dpoc.slovakia@organon.com |
Italia Addenda Pharma S.r.l., Tel: +39-06-9139 3303 addendapharma@legalmail.it | Suomi/Finland Organon Finland Oy Puh/Tel: +358 (0) 29 170 3520 dpoc.finland@organon.com |
Κύπρος Organon Pharma B.V., Cyprus branch Τηλ: +357 22866730 dpoc.cyprus@organon.com | Sverige Organon Sweden AB Tel: +46 8 502 597 00 dpoc.sweden@organon.com |
Latvija Arvalsts komersanta “Organon Pharma B.V.” parstavnieciba Tel: +371 66968876 dpoc.latvia@organon.com | United Kingdom (Northern Ireland) Organon Pharma (UK) Limited Tel: +44 (0) 208 159 3593 medicalinformationuk@organon.com |
Date of Last Revision of this Leaflet:<{MM/AAAA}>
Detailed information on this medicinal product is available on the European Medicines Agency website: https://www.ema.europa.eu.
The average price of ADROVANCE 70 mg/5,600 IU TABLETS in October, 2025 is around 17.92 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.